Company: BIAF
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004915
Chunk: 145

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: DRS
Chunk 145
---
 of the Company, effective November 5, 2024.                                                                  |
| (6) | Includes                                                                                                                                
 for 2024 the following amounts received by Mr. Girgenti for his service to the Company as a director: (i) in the Salary column —        
 $35,000, and (ii) in the Stock Awards column — $148,377.                                                                                |

Narrative Disclosure to Summary Compensation Table

Base Salaries

The Company uses base salaries to recognize the experience, skills, knowledge, and responsibilities required of all its employees, including the NEOs. Base salaries are reviewed annually and adjusted from time to time to realign salaries with market levels after taking into account individual responsibilities, performance, and experience. For 2024, the annual base salaries of the Company’s NEOs were:

| ● | For Ms. Zannes: $260,000                                                                                                           
 through October 31, 2024 and $300,000 commencing November 1, 2024 (which amounts do not include $25,000 in fees paid to Ms. Zannes 
 for her service as a director in 2024);                                                                                            |
| ● | For Mr. Edwards: $300,000(1);                                                                                                      
 and                                                                                                                                |
| ● | For Mr. Girgenti: $120,000                                                                                                         
 (which amount does not include $35,000 in fees paid to Mr. Girgenti for his service as a director in 2024).                        |

| (1) | Mr. Edwards’ employment                                                                                                                  
 agreement provides that he will receive an annual base salary of $300,000. Mr. Edwards was employed pursuant to such agreement as of     
 November 5, 2024, accordingly, he received a pro-rated portion of such salary in 2024. In addition, he served as a consultant to Company 
 from September 16, 2024 through October 31, 2024 for which he was paid consulting fees of $31,438.                                       |

Bonuses

On January 26, 2024, the Compensation Committee adopted the bioAffinity Technologies, Inc. Management Incentive Bonus Plan. The purpose of the Bonus Plan is to align officers’ and other employees’ efforts with the strategic goals of the Company through competitive annual incentive opportunities. The Bonus Plan is administered by the Compensation Committee. The Compensation Committee has the power to grant awards under the Bonus Plan, determine the amount of cash and/or equity to be paid pursuant to each award and